Stat3 Peptide Inhibitor
| Catalog number: | B2019254 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 mg |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Stat3 Peptide Inhibitor |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X. Targeting STAT3 in Cancer Immunotherapy Mol Cancer. 2020 Sep 24;19(1):145.
- Ma JH, Qin L, Li X. Role of STAT3 signaling pathway in breast cancer Cell Commun Signal. 2020 Feb 28;18(1):33.
- Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization Chem Biol. 2006 Nov;13(11):1235-42.
- Liu Y, Liao S, Bennett S, Tang H, Song D, Wood D, Zhan X, Xu J. STAT3 and its targeting inhibitors in osteosarcoma Cell Prolif. 2021 Feb;54(2):e12974.
- Song J, Wang J, Tian S, Li H. Discovery of STAT3 Inhibitors: Recent Advances and Future Perspectives Curr Med Chem. 2023;30(16):1824-1847.
- Ye S, Luo W, Khan ZA, Wu G, Xuan L, Shan P, Lin K, Chen T, Wang J, Hu X, Wang S, Huang W, Liang G. Celastrol Attenuates Angiotensin II-Induced Cardiac Remodeling by Targeting STAT3 Circ Res. 2020 Apr 10;126(8):1007-1023.
- Dong J, Cheng XD, Zhang WD, Qin JJ. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation J Med Chem. 2021 Jul 8;64(13):8884-8915.
- Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions Nat Rev Cancer. 2014 Nov;14(11):736-46.
- Chen Q, Hu Q, Chen Y, Shen N, Zhang N, Li A, Li L, Li J. PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer Cell Death Dis. 2023 Oct 9;14(10):655.
